Teng Yanbin, Ma Jianxiong, Ma Xinlong, Wang Ying, Lu Bin, Guo Chaowei
Biomechanics Labs of Orthopaedics Institute, Tianjin Hospital, Tianjin, PR China.
Medicine (Baltimore). 2017 Apr;96(17):e6763. doi: 10.1097/MD.0000000000006763.
Total joint arthroplasty (TJA) usually results in postoperative bleeding. Some randomized controlled trials (RCTs) and nonrandomized controlled trials (non-RCTs) have been performed to evaluate the effects of epinephrine on postoperative bleeding after TJA. However, this remained controversial about the efficacy and safety of epinephrine for postoperative bleeding in TJA. The objective of our meta-analysis was to compare the overall effect and safety of epinephrine and placebo for postoperative bleeding in TJA.
PubMed, Embase, and the Cochrane Library were searched to identify potentially relevant articles. RCTs or non-RCTs involving epinephrine and placebo for blood loss in total knee arthroplasty or total hip arthroplasty were included. Our study was performed based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. RevMan v5.3 was used to analyze the relevant data.
Four RCTs and 1 non-RCT involving 646 participants met the inclusion criteria. The overall pooled results from meta-analysis demonstrated that compared with control groups, epinephrine groups could significantly reduce the postoperative bleeding volume (mean difference [MD] = -168.42, 95% confidence interval [CI]: -272.37 to -64.47, P = 0.001). There was no significant difference in intraoperative bleeding volume between epinephrine and control groups (MD = -12.89, 95% CI: -53.45 to 27.69, P = 0.53). No significant difference was found between 2 groups in terms of postoperative hemoglobin loss (MD = -0.28, 95% CI: -0.66 to 0.10, P = 0.15). Compared with the control groups, no statistically significant difference was found in terms of postoperative transfusion rate in epinephrine groups (relative risk [RR] 0.86, 95% CI: 0.64-1.15, P = 0.31). In addition, the results of the meta-analysis also indicated no significant difference in terms of the incidence rate of deep venous thrombosis (DVT) between 2 groups (RR 0.28, 95% CI: 0.05-1.64, P = 0.16).
The meta-analysis showed that epinephrine could significantly reduce postoperative bleeding volume in TJA without increasing the incidence of DVT. However, there was no significant reduction in intraoperative bleeding volume, postoperative hemoglobin loss, and transfusion rate after the administration of epinephrine.
In this study, a higher heterogeneity and a risk of selection bias may be present in postoperative hemoglobin loss. In addition, the sample size of the included studies was too small, so our findings need to be further validated with more high-quality and larger scale RCTs in the future.
None.
全关节置换术(TJA)术后通常会出血。一些随机对照试验(RCT)和非随机对照试验(非RCT)已开展,以评估肾上腺素对TJA术后出血的影响。然而,关于肾上腺素用于TJA术后出血的疗效和安全性仍存在争议。我们进行荟萃分析的目的是比较肾上腺素和安慰剂对TJA术后出血的总体效果和安全性。
检索PubMed、Embase和Cochrane图书馆,以识别潜在相关文章。纳入涉及肾上腺素和安慰剂用于全膝关节置换术或全髋关节置换术失血情况的RCT或非RCT。我们的研究依据系统评价和荟萃分析的首选报告项目声明进行。使用RevMan v5.3分析相关数据。
四项RCT和一项非RCT共646名参与者符合纳入标准。荟萃分析的总体汇总结果表明,与对照组相比,肾上腺素组可显著减少术后出血量(平均差[MD]=-168.42,95%置信区间[CI]:-272.37至-64.47,P=0.001)。肾上腺素组与对照组术中出血量无显著差异(MD=-12.89,95%CI:-53.45至27.69,P=0.53)。两组术后血红蛋白损失无显著差异(MD=-0.28,95%CI:-0.66至0.10,P=0.15)。与对照组相比,肾上腺素组术后输血率无统计学显著差异(相对危险度[RR]0.86,95%CI:0.64-1.15,P=0.31)。此外,荟萃分析结果还表明,两组深静脉血栓形成(DVT)发生率无显著差异(RR 0.28,95%CI:0.05-1.64,P=0.16)。
荟萃分析表明,肾上腺素可显著减少TJA术后出血量,且不增加DVT发生率。然而,使用肾上腺素后术中出血量、术后血红蛋白损失和输血率无显著降低。
本研究中,术后血红蛋白损失可能存在较高异质性和选择偏倚风险。此外,纳入研究的样本量过小,因此我们的研究结果未来需要更多高质量、大规模的RCT进一步验证。
无。